Missing: R2 Technologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: R2 Technologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing R2 Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
R2 Technologies is included in 2 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Latest R2 Technologies News
May 3, 2022
News provided by Share this article Share this article SAN RAMON, Calif., May 3, 2022 /PRNewswire/ -- R2 Technologies Inc. ("R2"), the world leader in CryoAesthetic™ medical devices, today announced that data related to GLACIAL®Rx, the first-to-market controlled cooling platform of its kind, was presented during the annual meeting of the American Society for Laser Medicine and Surgery (ASLMS) which took place from April 27-30, in San Diego, CA. Favorable data regarding the GLACIAL®Rx device were highlighted in two oral presentations during the meeting. Safety and Efficacy of Cryomodulation for the Improvement of Photodamaged Skin. Presented by: Dr. Hayley Leight-Dunn. Author: Dr. Girish Munavalli. "The data presented at the ASLMS meeting underscore the clinical benefits of the GLACIAL® Rx platform." Presented by: Dr. Ashish Bhatia A Pilot Clinical Evaluation of a Precision Freezing Device for Improvement of Recalcitrant Psoriatic Plaque Presented by: Dr. Hayley Leight-Dunn Author: Dr. Girish Munavalli "The data presented at the ASLMS meeting underscore the clinical benefits of the GLACIAL® Rx platform, and the potential for our precision contact cooling modalities," says Tim Holt, R2's Chief Executive Officer. "These are the first academic data presented that demonstrate the benefits of controlled cooling to both improve the appearance of inflamed, photodamaged skin, and provide some symptomatic relief from painful psoriatic plaques. We will continue to invest in R&D programs and research studies that explore dermatalogical benefits of the GLACIAL® Rx platform." In addition to the data presentations, R2 hosted a Scientific Advisory Board during the ASLMS annual meeting. Advisory board attendees included the physicians who developed the GLACIAL® Rx technology including Dr. Rox Anderson, Dr. Dieter Manstein and Dr. Henry Chan. R2 recently passed a milestone with 100 commercial devices placed in the market, delivering over 15,000 treatment cycles, and will be celebrating with hashtag #Glacial100 in the coming weeks. About R2 Technologies Headquartered in Silicon Valley, R2 Technologies is the world leader in CryoAesthetic™ medical devices, including the GLACIAL® platform for precision contact cooling of the skin, which has been shown to reduce inflammation and also brighten dark spots. In 2014, Pansend Life Sciences, LLC and Blossom Innovations, LLC founded R2 Technologies and licensed exclusive intellectual property from Massachusetts General Hospital. In 2019, R2 brought on strategic partner, Huadong Medicine Co., Ltd. In close collaboration with these partners and the brand's scientiﬁc founders and world-famous luminaries in aesthetic medicine, Drs. Rox Anderson, Dieter Manstein, and Henry Chan, R2 focuses on the development, engineering, clinical research, and commercialization of groundbreaking technologies for aesthetic providers and consumers. Since inception, R2 has raised $76 million in ﬁnancing led by a world-class team of experts within the aesthetics industry. To learn more about R2 Technologies, treatment offerings and providers, visit glacialskin.com and follow the company on LinkedIn and Instagram . SOURCE R2 Technologies
R2 Technologies Frequently Asked Questions (FAQ)
When was R2 Technologies founded?
R2 Technologies was founded in 2014.
Where is R2 Technologies's headquarters?
R2 Technologies's headquarters is located at 2603 Camino Ramon, San Ramon.
What is R2 Technologies's latest funding round?
R2 Technologies's latest funding round is Series C.
How much did R2 Technologies raise?
R2 Technologies raised a total of $45M.
Who are the investors of R2 Technologies?
Investors of R2 Technologies include HC2 Holdings and Huadong Medicine.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.